{
  "itemId": "MISSION-500-76-1771347686187-DKA-CerebralEdema",
  "itemType": "highlight",
  "caseId": "a9b8c7d6-e5f4-4a3b-9c2d-1e0f9a8b7c6d",
  "question": "The nurse is reviewing the client's electronic health record (EHR) before titrating the insulin infusion according to the DKA protocol. Click to highlight the findings in the nurse's note that are of most immediate concern and require the nurse to withhold the planned action.",
  "tabs": [
    {
      "tabId": "nursesNote",
      "tabName": "Nurses' Note",
      "tabContent": {
        "type": "text",
        "header": "0900 - Emergency Department Nurse's Note",
        "body": "Client is a 19-year-old with a history of type 1 diabetes mellitus admitted 2 hours ago with DKA, reportedly after running out of insulin. Initial assessment revealed lethargy, nausea, and abdominal pain. Fruity odor on breath and deep, rapid respirations (Kussmaul respirations noted). Client is receiving 0.9% sodium chloride and a regular insulin infusion. Fingerstick glucose is now 550 mg/dL, down from 650 mg/dL on admission. Urine output was 150 mL in the past 2 hours. Client now complains of a new, worsening headache and seems more drowsy than on the previous assessment. When aroused, client is oriented to person only. Just vomited once without nausea. Family at bedside is highly anxious."
      }
    },
    {
      "tabId": "vitals",
      "tabName": "Vital Signs",
      "tabContent": {
        "type": "table",
        "header": "Vital Signs Trend",
        "data": [
          {
            "label": "Time",
            "values": [
              "0700 (Admission)",
              "0900 (Current)"
            ]
          },
          {
            "label": "Heart Rate",
            "values": [
              "128 bpm",
              "56 bpm"
            ]
          },
          {
            "label": "Blood Pressure",
            "values": [
              "92/58 mmHg",
              "160/82 mmHg"
            ]
          },
          {
            "label": "Respiratory Rate",
            "values": [
              "32/min, deep",
              "12/min, irregular"
            ]
          },
          {
            "label": "Temperature",
            "values": [
              "37.1째C (98.8째F)",
              "37.3째C (99.1째F)"
            ]
          },
          {
            "label": "SpO2",
            "values": [
              "96% on room air",
              "95% on room air"
            ]
          }
        ]
      }
    },
    {
      "tabId": "labs",
      "tabName": "Laboratory Results",
      "tabContent": {
        "type": "table",
        "header": "Current Serum Chemistry",
        "data": [
          {
            "label": "Test",
            "value": "Result",
            "referenceRange": "Reference"
          },
          {
            "label": "Glucose",
            "value": "550 mg/dL",
            "referenceRange": "70-110 mg/dL"
          },
          {
            "label": "Sodium",
            "value": "128 mEq/L",
            "referenceRange": "136-145 mEq/L"
          },
          {
            "label": "Potassium",
            "value": "3.4 mEq/L",
            "referenceRange": "3.5-5.0 mEq/L"
          },
          {
            "label": "Chloride",
            "value": "95 mEq/L",
            "referenceRange": "98-106 mEq/L"
          },
          {
            "label": "Bicarbonate (HCO3)",
            "value": "10 mEq/L",
            "referenceRange": "22-26 mEq/L"
          },
          {
            "label": "BUN",
            "value": "35 mg/dL",
            "referenceRange": "10-20 mg/dL"
          },
          {
            "label": "Creatinine",
            "value": "1.6 mg/dL",
            "referenceRange": "0.6-1.2 mg/dL"
          },
          {
            "label": "Anion Gap",
            "value": "23",
            "referenceRange": "8-12 mEq/L"
          }
        ]
      }
    },
    {
      "tabId": "mar",
      "tabName": "MAR",
      "tabContent": {
        "type": "table",
        "header": "Medication Administration Record - Active Infusions",
        "data": [
          {
            "label": "Medication",
            "value": "Dose/Rate",
            "notes": "Notes"
          },
          {
            "label": "0.9% Sodium Chloride",
            "value": "Continuous IV Infusion at 250 mL/hr",
            "notes": "1 liter bolus given over 1st hour in ED."
          },
          {
            "label": "Regular Insulin",
            "value": "Continuous IV Infusion at 7 units/hr (0.1 units/kg/hr)",
            "notes": "Protocol: Titrate hourly to decrease blood glucose by 50-75 mg/dL/hr."
          }
        ]
      }
    }
  ],
  "answer": {
    "key": [
      "complains of a new, worsening headache",
      "seems more drowsy",
      "vomited once without nausea"
    ]
  },
  "answerBreakdown": {
    "overallRationale": "The client's presentation suggests possible cerebral edema, a dangerous complication of DKA treatment, especially in young adults. Rapid correction of hyperglycemia can cause a fluid shift into the brain, leading to increased intracranial pressure (ICP). The nurse should immediately withhold further insulin titration and notify the provider. The new headache, decreased level of consciousness (drowsiness, oriented to person only), and vomiting without nausea are all red flags for increased ICP. The bradycardia and hypertension (Cushing's triad) further support this concern. Continuing to lower the blood glucose rapidly could worsen the cerebral edema. Interventions may include slowing or stopping IV fluids, administering mannitol or hypertonic saline to reduce cerebral edema, and preparing for possible intubation.",
    "optionBreakdown": [
      {
        "option": "complains of a new, worsening headache",
        "rationale": "Correct. A new or worsening headache is a significant symptom of increased ICP and cerebral edema. The headache results from the expanding brain tissue pressing on pain-sensitive structures within the skull. This requires immediate attention.",
        "isCorrect": true
      },
      {
        "option": "seems more drowsy",
        "rationale": "Correct. Drowsiness and a decreased level of consciousness indicate neurological compromise. As ICP increases, it affects the reticular activating system (RAS) in the brainstem, which is responsible for maintaining wakefulness and alertness.",
        "isCorrect": true
      },
      {
        "option": "vomited once without nausea",
        "rationale": "Correct. Vomiting without preceding nausea is a classic sign of increased ICP. The pressure on the brainstem can directly stimulate the vomiting center, bypassing the usual nausea pathway.",
        "isCorrect": true
      },
      {
        "option": "Fruity odor on breath and deep, rapid respirations (Kussmaul respirations noted)",
        "rationale": "Incorrect. These are expected findings in DKA. Kussmaul respirations are the body's attempt to compensate for metabolic acidosis by blowing off carbon dioxide. The fruity odor is due to acetone, a ketone body produced during fat breakdown.",
        "isCorrect": false
      },
      {
        "option": "Fingerstick glucose is now 550 mg/dL, down from 650 mg/dL on admission",
        "rationale": "Incorrect. While a high glucose level is concerning, the fact that it is decreasing indicates the insulin is working. The priority is to address the neurological changes, as rapid glucose reduction could exacerbate cerebral edema.",
        "isCorrect": false
      },
      {
        "option": "Urine output was 150 mL in the past 2 hours",
        "rationale": "Incorrect. This urine output suggests adequate renal perfusion and is a positive sign. Cerebral edema, not renal function, is the immediate threat.",
        "isCorrect": false
      },
      {
        "option": "reportedly after running out of insulin",
        "rationale": "Incorrect. This is background information explaining the cause of the DKA but does not represent an acute change in the client's condition requiring immediate intervention.",
        "isCorrect": false
      }
    ]
  },
  "clinicalPearls": "Clinical Pearl: Be vigilant for signs of cerebral edema in children and young adults with DKA, especially during the initial phase of treatment. Early recognition and intervention are crucial to prevent permanent neurological damage or death.\n\nClinical Pearl: Cushing's triad (bradycardia, hypertension with widening pulse pressure, and irregular respirations) is a late sign of increased ICP and indicates impending brain herniation. Immediate action is required.\n\nClinical Pearl: Always prioritize neurological assessments in patients with DKA, and be prepared to adjust treatment plans based on changes in mental status.\n\nClinical Pearl: Avoid overly rapid correction of hyperglycemia in DKA, especially in pediatric patients. Aim for a gradual reduction in blood glucose to minimize the risk of cerebral edema.",
  "sentinelStatus": "healed_v2026_v8"
}